Germline heterozygous deletion containing CDKN2A/CDKN2B as genetic substrate for rare familial neural and skin tumor syndrome

被引：0
|
作者：
Hannes, Laurens [1 ,2 ]
Brems, Hilde [1 ,2 ]
Clement, Paul [3 ]
De Vleeschouwer, Steven [4 ]
Garmyn, Marjan [5 ]
Sciot, Raf [6 ]
Van Calenbergh, Frank
Legius, Eric [2 ]
机构：
[1] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium
[2] UZ Leuven, Ctr Human Genet, Leuven, Belgium
[3] Katholieke Univ Leuven, Leuven Canc Inst, Leuven, Belgium
[4] UZ Leuven, Dept Neurosurg, Leuven, Belgium
[5] UZ Leuven, Dept Dermatol, Leuven, Belgium
[6] UZ Leuven, Dept Pathol, Leuven, Belgium
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P13.109.A
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [1] Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
    Sock Hoai Chan
    Weng Khong Lim
    Scott T Michalski
    Jing Quan Lim
    Nur Diana Binte Ishak
    Marie Met-Domestici
    Cedric Ng Chuan Young
    Karen Vikstrom
    Edward D Esplin
    Jennifer Fulbright
    Mei Kim Ang
    Joseph Wee
    Kesavan Sittampalam
    Mohamad Farid
    Stephen E Lincoln
    Koji Itahana
    Syafiq Abdullah
    Bin Tean Teh
    Joanne Ngeow
    npj Genomic Medicine, 1
  • [2] Germline Co-deletion of CDKN2A and CDKN2B Genes in Pleomorphic Xanthoastrocytoma: Case Report
    Agiannitopoulos, Konstantinos
    Katseli, Anastasia
    Potska, Kevisa
    Ntogka, Christina
    Tsaousis, Georgios N.
    Tsoulos, Nikolaos
    Kampoli, Katerina
    Ntavatzikos, Anastasios
    Papadopoulou, Eirini
    Nasioulas, George
    Koumarianou, Anna
    IN VIVO, 2024, 38 (04): : 1671 - 1676
  • [3] Molecular genetic analysis of oligodendroglial tumors for alterations of the CDKN2A and CDKN2B tumor suppressor genes
    Wolter, M
    Reifenberger, J
    Ichimura, K
    Schmidt, EE
    Collins, VP
    Reifenberger, G
    BRAIN PATHOLOGY, 2000, 10 (04) : 570 - 571
  • [4] Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients
    Kiatprungvech, Nattaradee
    Sangkum, Premsant
    Malinee, Rozita
    Sommaluan, Suchada
    Korkiatsakul, Veerawat
    Worawichawong, Suchin
    Rerkamnuaychoke, Budsaba
    Kongruang, Adcharee
    Aeesoa, Suraida
    Lertsithichai, Panuwat
    Kijvikai, Kittinut
    Kongchareonsombat, Wisoot
    Siriboonpiputtana, Teerapong
    PRACTICAL LABORATORY MEDICINE, 2024, 40
  • [5] Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
    Platz, A
    Hansson, J
    ManssonBrahme, E
    Lagerlof, B
    Linder, S
    Lundqvist, E
    Sevigny, P
    Inganas, M
    Ringborg, U
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (10) : 697 - 702
  • [6] Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans
    Lee, Ho-Su
    Lee, Soo Bin
    Kim, Byoung Mok
    Hong, Myunghee
    Jung, Seulgi
    Hong, Jeonghoon
    Baek, Jiwon
    Han, Buhm
    Oh, Seak Hee
    Kim, Kyung Mo
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Ye, Byong Duk
    Song, Kyuyoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (04) : 887 - 893
  • [7] INTRAGENIC MUTATIONS OF CDKN2B AND CDKN2A IN PRIMARY HUMAN ESOPHAGEAL CANCERS
    SUZUKI, H
    ZHOU, XL
    YIN, J
    LEI, JY
    JIANG, HY
    SUZUKI, Y
    CHAN, T
    HANNON, GJ
    MERGNER, WJ
    ABRAHAM, JM
    MELTZER, SJ
    HUMAN MOLECULAR GENETICS, 1995, 4 (10) : 1883 - 1887
  • [8] CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
    Tu, Q.
    Hao, J.
    Zhou, X.
    Yan, L.
    Dai, H.
    Sun, B.
    Yang, D.
    An, S.
    Lv, L.
    Jiao, B.
    Chen, C.
    Lai, R.
    Shi, P.
    Zhao, X.
    ONCOGENE, 2018, 37 (01) : 128 - 138
  • [9] CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
    Q Tu
    J Hao
    X Zhou
    L Yan
    H Dai
    B Sun
    D Yang
    S An
    L Lv
    B Jiao
    C Chen
    R Lai
    P Shi
    X Zhao
    Oncogene, 2018, 37 : 128 - 138
  • [10] CDKN2A and CDKN2B methylation in coronary heart disease cases and controls
    Zhong, Jinyan
    Chen, Xiaoying
    Ye, Huadan
    Wu, Nan
    Chen, Xiaomin
    Duan, Shiwei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (06) : 6093 - 6098
12345